@author-1788515151757110
We sincerely invite top scientists to visit the S2SChina website and submit proposals, embarking on an accelerated journey from the lab to entrepreneurship.
Qiming Venture Partners led Alamar Biosciences' Series A round in 2020, and continued to back the company in its Series B and C rounds.
The real moat of a scientific product doesn't come from any single breakthrough, but from the feedback, refinement, and repeated iteration that comes from sustained customer use.
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
This ranking systematically maps the landscape, growth momentum, and evolutionary trajectory of China's new economy enterprises.
An international innovative biopharmaceutical company focused on the R&D of extrahepatic-targeted small nucleic acid drugs
Global leader in innovative tumor immunotherapy
Staying with you to mark the milestone moments of Qiming Venture Partners' portfolio companies.
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
a leading player in China's disposable endoscope market
